16. Juni 2017
Background: Fabry disease (FD), an X-linked lysosomal storage disorder, results from the deficient activity of α-galactosidase A (α-Gal A)...Read more
3. Januar 2017
Background: Fabry disease is an X-linked lysosomal storage disorder due to α-galactosidase A (α-Gal A) deficiency. Clinical onset of...Read more
19. Oktober 2016
Background: Fabry disease (FD) is a rare X-linked lysosomal storage disorder due to mutations in the a-galactosidase A gene (GLA)...Read more
21. September 2016
ARCHIMEDlife started offering genetic testing for Gaucher, Niemann-Pick A/B, MPS-I, Pompe and Fabry disease. More recently, we expanded our...Read more
21. September 2016
In the healthy cell metabolism homocysteine is a short-living intermediate product, which is either transformed or removed by various...Read more
21. Juni 2016
Background: In classical homocystinuria (HCU, MIM# 236200) due to the deficiency of cystathionine β-synthase (EC 188.8.131.52) there is a...Read more
24. März 2016
High consanguinity rates, poor access to accurate diagnostic tests, and costly therapies are the main causes of increased burden...Read more
14. Juli 2015
Introduction: Bacterial involvement is believed to play a pivotal role in the development and disease outcome of NEC. However,...Read more
15. Januar 2015
BACKGROUND: We aimed to determine the incidence of primary gestational infections with Toxoplasma gondii and congenital toxoplasmosis in Austria, a...Read more
13. November 2014
In 1966, the National Austrian Newborn Screening Program for inherited metabolic and endocrine disorders was initiated. In the last...Read more
Started in 2013, ARCHIMEDlife is an independent highly-innovative company dedicated in providing and developing diagnostic services from Inborn Errors of Metabolism to Oncological Diseases. Our commitment is to provide better and faster high-quality laboratory tests for you and your family.
Our diagnostic laboratory is offering services from Clinical Mass Spectrometry to Next-Generation Sequencing. We have international collaborations with physicians, clinical researchers and industry specialized in personalized health care.
We are dedicated to the development of novel laboratory tests to to make actionable health information accessible at the time it matters.